Download presentation
Presentation is loading. Please wait.
Published byOlivia Davidson Modified over 9 years ago
1
U.S. IPO Market Update Presented by Guy Cohen Executive Director, Head of Israeli Investment Banking, Oppenheimer June 28, 2010
2
Capital Markets Update
3
3 Market Performance Since 2007 Note: 3/6/09 marked a 17-year intraday low on the S&P 500
4
4 CBOE Volatility Index (VIX) Since 1/2007 Market volatility has declined but is not stable yet Source: FactSet as of 6/18/10 Volatility
5
5 Global Economy Market Outlook The global financial crisis is abating although the recovery is fragile and risks remain Global GDP contracted by 0.6% in 2009, the first decline in world output since World War II Source: IMF (GDP figures from 2010 – 2011 are estimates) Annual % GDP Growth for Selected Countries, 2008 – 2011
6
6 US Unemployment It is our belief that companies cut jobs too deeply and that unemployment in the US will come down as the economic recovery continues The unemployment rate jumped from 5.7% in July ’08 to 10.2% in October ’09 (the highest level since December 1982 when unemployment reached 10.8%) Job creation will be a major driver of consumer sentiment and consumption Source: BLS, CME, FactSet, S&P Non-Farm Payrolls
7
IPO Market Overview
8
8 Equity Issuance Total Equity Issuance (# of Deals) Source: Dealogic Number of Deals
9
9 Q1 and Q2 2010 vs. Q1 and Q2 2009 Comparison Number of IPOs Source: Dealogic, FactSet as of 6/24/10; Excludes SPACs and IPOs less than $20 million
10
10 IPO Issuance in Perspective Source: Dealogic, FactSet as of 12/31/09; Excludes SPACs and IPOs less than $20 million Nasdaq vs. 3-Month Rolling Average IPO Issuance
11
11 2010 YTD IPO Market Score Card
12
12 IPO Issuance in Perspective Source: Dealogic, FactSet as of 6/24/10; Excludes SPACs and IPOs less than $20 million 2010 Weekly number of IPOs
13
13 2010 YTD IPO Market Score Card Monthly Price Performance & Issuance of IPOs Source: Dealogic, FactSet as of 6/14/10; Excludes SPACs and IPOs less than $20 million
14
14 IPO Sizing Analysis Source: Dealogic as of 6/21/10, deal values ≥ $20M and exclude overallotment, excludes SPACs
15
15 IPO Issuance by Market Capitalization Source: Dealogic, FactSet as of 6/27/10; Excludes SPACs and IPOs less than $20 million
16
16 Is the US Market Open for Israeli Companies Historically mostly Israeli IPOs Tech and Healthcare Average Deal Size $50-75mm Average Market cap $250-500mm 2010 IPOs in US Technology – 17 IPOs Healthcare – 8 IPOs Foreign Private Issuer advantage
17
17 Is the US Market Open for Israeli Companies Various differentiating factors by industry Revenue, Growth Rate, Profitability, Market Size, IP, Competitive Environment Source: Dealogic as of 6/21/10, deal values ≥ $20M and exclude overallotment, excludes SPACs 20072010 YTD LQ Median Revenue$25.8M$36.2M LQ Median Net-Income$1.1M$2.8M Last Quarter Revenue and Net Income of all IPOs in 2007 and 2010 YTD
18
Exchange Comparison
19
19 Maturity Exchange/ Investor Type Expansion Growth Initial Sales R&D Concept Venture Capital Private Equity AIM Candidates TSX Candidates NASDAQ Candidates Investor and Exchange Stages PE VC Note: Qualitative graph TASE Candidates
20
20 US Listing Advantages Liquidity Research Coverage Technology and Healthcare Orientation Shares as Acquisition Currency Valuation Israeli Companies Acceptance Consideration point: Regulatory Environment
21
Thank You! guy.cohen@opco.com Office: +972 3 5262627
Similar presentations
© 2025 SlidePlayer.com. Inc.
All rights reserved.